{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:04:46Z","timestamp":1774616686606,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lower baseline antipneumolysin antibody (\u03b1 -PLY) levels have been found in populations with a higher incidence of pneumococcal infections. To determine whether predisease \u03b1 -PLY titer is associated with invasive pneumococcal disease in HIV-seropositive injection drug users (IDU), we utilized a prospective cohort of IDU in Baltimore to compare \u03b1 -PLY titers before bacteremia in 28 HIV- seropositive IDU cases with \u03b1 -PLY titers in 56 matched (CD4 and seroconversion date) HIV-seropositive IDU control subjects and 28 matched (calendar time) HIV-seronegative IDU control subjects remaining free of pneumococcal disease. We also compared the postinfection fold-rise of \u03b1 -PLY titers in cases relative to the change in \u03b1 -PLY titers in control subjects during the same interval; \u03b1 -PLY titers were measured using quantitative ELISA, and functional activity was assessed using antihemolysin assays. Predisease \u03b1 -PLY titer did not differ between cases (66 units) and HIV-seropositive control subjects (70 units, p = 0.56) or HIV-seronegative control subjects (80 units, p = 0.10). There was a significant difference in fold-rise of \u03b1 -PLY titers postdisease between cases (1.18) and HIV-seronegative control subjects (0.76), p = 0.03. Baseline \u03b1 -PLY titers do not differ significantly between HIV-seropositive IDU who develop pneumococcal bacteremia from HIV-seropositive and HIV-seronegative IDU control subjects remaining free of severe pneumococcal disease.<\/jats:p>","DOI":"10.1164\/ajrccm.163.3.2002066","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:34:29Z","timestamp":1365086069000},"page":"680-684","source":"Crossref","is-referenced-by-count":4,"title":["Antipneumolysin Antibody Titers in HIV-Seropositive Injection Drug Users before and after Pneumococcal Bacteremia"],"prefix":"10.1093","volume":"163","author":[{"given":"JEFFREY H.","family":"SULLIVAN","sequence":"first","affiliation":[{"name":"Johns Hopkins School of Medicine and Johns Hopkins School of Public Health, Department of International Health, Baltimore, Maryland; and University of Glasgow, Division of Infection and Immunity, Glasgow, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIMOTHY J.","family":"MITCHELL","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine and Johns Hopkins School of Public Health, Department of International Health, Baltimore, Maryland; and University of Glasgow, Division of Infection and Immunity, Glasgow, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARK C.","family":"STEINHOFF","sequence":"additional","affiliation":[{"name":"Johns Hopkins School of Medicine and Johns Hopkins School of Public Health, Department of International Health, Baltimore, Maryland; and University of Glasgow, Division of Infection and Immunity, Glasgow, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,3,1]]},"reference":[{"key":"2026032708175111500_B1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-117-4-314","article-title":"Pneumococcal disease during HIV-infection: epidemiologic, clinical and immunologic perspectives.","volume":"117","author":"Janoff","year":"1992","journal-title":"Ann Intern Med"},{"key":"2026032708175111500_B2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/infdis\/167.1.49","article-title":"S. pneumoniae colonization, bacteremia, and immune response among persons with HIV.","volume":"167","author":"Janoff","year":"1993","journal-title":"J Infect Dis"},{"key":"2026032708175111500_B3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/173.4.857","article-title":"Risk factors for pneumococcal infections in HIV-infected patients.","volume":"173","author":"Gebo","year":"1996","journal-title":"J Infect Dis"},{"key":"2026032708175111500_B4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199509283331305","article-title":"Bacterial pneumonia in persons infected with HIV.","volume":"333","author":"Hirshtick","year":"1995","journal-title":"N Engl J Med"},{"key":"2026032708175111500_B5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/162.5.1012","article-title":"The role of HIV in pneumococcal bacteremia in San Francisco residents.","volume":"162","author":"Redd","year":"1990","journal-title":"J Infect Dis"},{"key":"2026032708175111500_B6","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.1997.00440380069007","article-title":"Adult bacteremic pneumococcal pneumonia in a community teaching hospital.","volume":"157","author":"Watanakunakorn","year":"1997","journal-title":"Arch Intern Med"},{"key":"2026032708175111500_B7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/clinids\/23.3.577","article-title":"Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without HIV.","volume":"23","author":"Frankel","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2026032708175111500_B8"},{"key":"2026032708175111500_B9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/clinids\/14.4.801","article-title":"Infections caused by S. pneumoniae: clinical spectrum, pathogenesis, immunity and treatment.","volume":"14","author":"Musher","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2026032708175111500_B10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-2143(98)90073-7","article-title":"Pneumolysin: a multifunctional pneumococcal virulence factor.","volume":"131","author":"Rubins","year":"1998","journal-title":"J Lab Clin Med"},{"key":"2026032708175111500_B11"},{"key":"2026032708175111500_B12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1172\/JCI117631","article-title":"Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.","volume":"95","author":"Rubins","year":"1995","journal-title":"J Clin Invest"},{"key":"2026032708175111500_B13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/jcm.26.1.96-100.1988","article-title":"Serum antibodies to pneumolysin in patients with pneumonia.","volume":"26","author":"Kanclerski","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2026032708175111500_B14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/cdli.2.6.704-707.1995","article-title":"Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media.","volume":"2","author":"Virolainen","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"2026032708175111500_B15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/iai.40.2.548-552.1983","article-title":"Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae.","volume":"40","author":"Paton","year":"1983","journal-title":"Infect Immun"},{"key":"2026032708175111500_B16"},{"key":"2026032708175111500_B17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/002204269102100406","article-title":"The ALIVE Study, a longitudinal study of HIV infection among IVDU: description of methods and characteristics of participants.","volume":"21","author":"Vlahov","year":"1991","journal-title":"J Drug Issues"},{"key":"2026032708175111500_B18","first-page":"1418","article-title":"ATS consensus conference on treatment of severe pneumonia.","volume":"148","author":"Neiderman","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2026032708175111500_B19","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1365-2958.1991.tb00812.x","article-title":"Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute phase protein.","volume":"5","author":"Mitchell","year":"1991","journal-title":"Mol Microbiol"},{"key":"2026032708175111500_B20"},{"key":"2026032708175111500_B21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0895-4356(88)90158-8","article-title":"Sample size determination in studies with matched pairs.","volume":"41","author":"Fleiss","year":"1985","journal-title":"J Clin Epidemial"},{"key":"2026032708175111500_B22","first-page":"590","article-title":"Colonization by S. pneumoniae among HIV-infected adults.","volume":"175","author":"Barradas","year":"1997","journal-title":"J Infect Dis"},{"key":"2026032708175111500_B23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0306-3623(94)00162-G","article-title":"Direct cellular immunomodulation produced by diacetylmorphine or methadone.","volume":"26","author":"Thomas","year":"1995","journal-title":"Gen Pharmacol"},{"key":"2026032708175111500_B24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1360-0443.1993.tb00809.x","article-title":"The effects of methadone on immune function among IDU; a review.","volume":"88","author":"McLachlan","year":"1993","journal-title":"Addiction"},{"key":"2026032708175111500_B25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/172.2.340","article-title":"Antibody class and subclass responses to pneumococcal polysaccharides following immunization of HIV-infected patients.","volume":"172","author":"Carson","year":"1995","journal-title":"J Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/163\/3\/680\/67548149\/ajrccm_163_3_680.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/163\/3\/680\/67548149\/ajrccm_163_3_680.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:18:00Z","timestamp":1774613880000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/163\/3\/680\/8541175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,3,1]]},"published-print":{"date-parts":[[2001,3,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.163.3.2002066","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,3]]},"published":{"date-parts":[[2001,3,1]]}}}